Nifty

:

17853.20

Sensex

:

60048.47

30.25 (0.17%)
163.11 (0.27%)

Login

Nifty
Sensex

:
:

17853.20
60048.47

30.25 (0.17%)
163.11 (0.27%)

Divi's Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

59/99

BSE: 532488 | NSE: DIVISLAB

Watchlist

NSE BSE

5108.55

24-Sep-2021

Open
High
Low
Previous Close

5235.35
5254.00
5092.00
5212.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

350328
18100.59
5271.65
3015.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

135,436.76
66.09
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

133,281.08
0.39%
13.75

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.10
11.39
12.11

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.26
14.61
8.84

PAT CAGR (%)

10 Years
5 Years
3 Years

14.04
13.35
13.62

P:E (Median)

8 Years
5 Years
3 Years

31.04
36.72
47.27

P:BV (Average)

8 Years
5 Years
3 Years

7.28
7.38
8.90

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.76
25.77
31.30

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 1,950.16 1,709.96 14.05% 1,718.39 1,376.24 24.86% 1,656.48 1,390.49 19.13% 1,713.78 1,403.92 22.07%
Expenses 1,098.69 1,010.98 8.68% 1,019.04 927.60 9.86% 978.03 893.62 9.45% 981.39 918.56 6.84%
EBITDA 851.47 698.98 21.82% 699.35 448.64 55.88% 678.45 496.87 36.54% 732.39 485.36 50.90%
EBIDTM 43.66% 40.88% 40.70% 32.60% 40.96% 35.73% 42.74% 34.57%
Other Income 35.55 17.87 98.94% 22.85 76.52 -70.14% 19.68 40.31 -51.18% 13.64 47.36 -71.20%
Interest 0.24 0.18 33.33% 0.18 0.40 -55.00% 0.22 1.55 -85.81% 0.11 3.79 -97.10%
Depreciation 73.01 55.97 30.44% 69.84 49.54 40.98% 67.95 46.69 45.53% 60.89 45.91 32.63%
PBT 813.77 660.70 23.17% 652.18 475.22 37.24% 629.96 488.94 28.84% 685.03 483.02 41.82%
Tax 261.80 168.45 55.42% 164.25 83.42 96.90% 168.72 128.21 31.60% 171.73 130.19 31.91%
PAT 551.97 492.25 12.13% 487.93 391.80 24.54% 461.24 360.73 27.86% 513.30 352.83 45.48%
PATM 28.30% 28.79% 28.39% 28.47% 27.84% 25.94% 29.95% 25.13%
EPS 20.79 18.54 12.14% 18.38 14.76 24.53% 17.37 13.59 27.81% 19.33 13.29 45.45%

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 1,960.64 1,730.47 13.30% 1,788.19 1,389.71 28.67% 1,701.44 1,396.26 21.86% 1,749.30 1,445.57 21.01%
Expenses 1,108.59 1,030.39 7.59% 1,071.93 945.26 13.40% 1,010.23 902.36 11.95% 1,008.16 955.01 5.57%
EBITDA 852.05 700.08 21.71% 716.26 444.45 61.16% 691.21 493.90 39.95% 741.14 490.56 51.08%
EBIDTM 43.46% 40.46% 40.05% 31.98% 40.63% 35.37% 42.37% 33.94%
Other Income 35.97 17.33 107.56% 23.52 76.73 -69.35% 19.32 41.67 -53.64% 13.64 47.03 -71.00%
Interest 0.28 0.23 21.74% 0.21 0.44 -52.27% 0.27 1.55 -82.58% 0.16 3.79 -95.78%
Depreciation 73.26 56.20 30.36% 70.08 49.78 40.78% 68.18 46.70 46.00% 61.13 45.93 33.09%
PBT 814.48 660.98 23.22% 669.49 470.96 42.15% 642.08 487.32 31.76% 693.49 487.87 42.15%
Tax 257.37 168.92 52.36% 167.47 82.73 102.43% 171.46 128.23 33.71% 173.90 131.09 32.66%
PAT 557.11 492.06 13.22% 502.02 388.23 29.31% 470.62 359.09 31.06% 519.59 356.78 45.63%
PATM 28.41% 28.43% 28.07% 27.94% 27.66% 25.72% 29.70% 24.68%
EPS 20.99 18.54 13.21% 18.91 14.63 29.25% 17.73 13.53 31.04% 19.57 13.44 45.61%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 7,038.81 6,798.61 5,310.57 4,879.66 3,815.94 4,023.85 3,721.33 3,084.01 2,513.97 2,128.89 1,844.93 Net Sales Growth 19.70% 28.02% 8.83% 27.88% -5.17% 8.13% 20.67% 22.67% 18.09% 15.39% Cost Of Goods Sold 2,273.04 2,265.50 2,088.56 1,837.83 1,504.90 1,541.58 1,495.70 1,215.44 918.14 797.66 761.21 Gross Profit 4,765.77 4,533.11 3,222.01 3,041.83 2,311.04 2,482.27 2,225.62 1,868.57 1,595.82 1,331.23 1,083.71 GP Margin 67.71% 66.68% 60.67% 62.34% 60.56% 61.69% 59.81% 60.59% 63.48% 62.53% 58.74% Total Expenditure 4,077.15 3,976.81 3,494.16 3,029.59 2,564.33 2,584.97 2,319.91 1,920.97 1,494.24 1,306.36 1,149.21 Power & Fuel Cost - 319.15 280.73 248.78 228.73 198.80 180.34 170.82 147.40 131.02 86.13 % Of Sales - 4.69% 5.29% 5.10% 5.99% 4.94% 4.85% 5.54% 5.86% 6.15% 4.67% Employee Cost - 808.68 608.36 530.72 446.27 490.33 352.95 283.15 225.43 191.20 145.16 % Of Sales - 11.89% 11.46% 10.88% 11.69% 12.19% 9.48% 9.18% 8.97% 8.98% 7.87% Manufacturing Exp. - 269.24 238.06 189.32 169.16 155.91 159.65 134.82 110.93 96.90 75.73 % Of Sales - 3.96% 4.48% 3.88% 4.43% 3.87% 4.29% 4.37% 4.41% 4.55% 4.10% General & Admin Exp. - 166.34 135.34 97.56 133.03 79.49 67.41 58.68 46.15 40.67 29.66 % Of Sales - 2.45% 2.55% 2.00% 3.49% 1.98% 1.81% 1.90% 1.84% 1.91% 1.61% Selling & Distn. Exp. - 110.21 75.11 62.51 58.37 59.82 50.37 45.83 39.64 47.70 50.06 % Of Sales - 1.62% 1.41% 1.28% 1.53% 1.49% 1.35% 1.49% 1.58% 2.24% 2.71% Miscellaneous Exp. - 37.69 68.00 62.87 23.87 59.04 13.48 12.23 6.55 1.21 50.06 % Of Sales - 0.55% 1.28% 1.29% 0.63% 1.47% 0.36% 0.40% 0.26% 0.06% 0.07% EBITDA 2,961.66 2,821.80 1,816.41 1,850.07 1,251.61 1,438.88 1,401.42 1,163.04 1,019.73 822.53 695.72 EBITDA Margin 42.08% 41.51% 34.20% 37.91% 32.80% 35.76% 37.66% 37.71% 40.56% 38.64% 37.71% Other Income 91.72 62.53 189.86 156.58 112.48 75.94 95.92 42.84 83.90 48.51 65.76 Interest 0.75 1.81 7.03 4.61 2.31 3.33 3.94 2.85 2.93 2.56 4.59 Depreciation 271.69 254.65 185.95 168.81 142.42 123.26 118.10 135.85 92.06 76.90 62.03 PBT 2,780.94 2,627.87 1,813.29 1,833.23 1,219.36 1,388.23 1,375.29 1,067.18 1,008.64 791.58 694.86 Tax 766.50 673.15 440.58 500.58 349.78 334.96 264.45 220.12 216.92 180.16 148.89 Tax Rate 27.56% 25.62% 24.30% 27.31% 28.69% 24.13% 19.23% 20.63% 21.51% 22.76% 21.43% PAT 2,014.44 1,954.72 1,372.71 1,332.65 869.58 1,053.27 1,110.84 847.06 791.72 611.42 545.97 PAT before Minority Interest 2,014.44 1,954.72 1,372.71 1,332.65 869.58 1,053.27 1,110.84 847.06 791.72 611.42 545.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 28.62% 28.75% 25.85% 27.31% 22.79% 26.18% 29.85% 27.47% 31.49% 28.72% 29.59% PAT Growth 26.09% 42.40% 3.01% 53.25% -17.44% -5.18% 31.14% 6.99% 29.49% 11.99% EPS 75.87 73.62 51.70 50.19 32.75 39.67 41.84 31.90 29.82 23.03 20.56

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 7,199.57 6,969.40 5,394.42 4,946.26 3,891.49 4,064.34 3,776.36 3,114.94 2,532.14 2,144.84 1,863.87 Net Sales Growth 20.76% 29.20% 9.06% 27.10% -4.25% 7.63% 21.23% 23.02% 18.06% 15.07% Cost Of Goods Sold 2,326.38 2,324.08 2,108.54 1,825.22 1,534.06 1,534.00 1,505.32 1,213.24 914.15 798.63 761.64 Gross Profit 4,873.19 4,645.32 3,285.88 3,121.04 2,357.43 2,530.34 2,271.04 1,901.70 1,617.99 1,346.21 1,102.23 GP Margin 67.69% 66.65% 60.91% 63.10% 60.58% 62.26% 60.14% 61.05% 63.90% 62.77% 59.14% Total Expenditure 4,198.91 4,108.23 3,571.21 3,073.24 2,628.74 2,617.20 2,358.04 1,948.69 1,516.76 1,328.87 1,172.59 Power & Fuel Cost - 319.15 280.73 248.78 228.73 198.80 180.34 170.82 147.40 131.02 86.13 % Of Sales - 4.58% 5.20% 5.03% 5.88% 4.89% 4.78% 5.48% 5.82% 6.11% 4.62% Employee Cost - 825.76 621.05 542.27 456.06 499.90 361.19 290.42 232.46 197.72 150.85 % Of Sales - 11.85% 11.51% 10.96% 11.72% 12.30% 9.56% 9.32% 9.18% 9.22% 8.09% Manufacturing Exp. - 297.84 258.91 212.96 182.67 169.15 169.42 147.24 121.10 104.85 86.61 % Of Sales - 4.27% 4.80% 4.31% 4.69% 4.16% 4.49% 4.73% 4.78% 4.89% 4.65% General & Admin Exp. - 175.26 148.62 105.30 139.33 88.22 73.91 63.85 51.74 44.15 32.47 % Of Sales - 2.51% 2.76% 2.13% 3.58% 2.17% 1.96% 2.05% 2.04% 2.06% 1.74% Selling & Distn. Exp. - 124.03 85.36 73.08 64.02 67.48 56.04 51.93 44.22 51.29 53.63 % Of Sales - 1.78% 1.58% 1.48% 1.65% 1.66% 1.48% 1.67% 1.75% 2.39% 2.88% Miscellaneous Exp. - 42.11 68.00 65.63 23.87 59.65 11.80 11.18 5.69 1.21 53.63 % Of Sales - 0.60% 1.26% 1.33% 0.61% 1.47% 0.31% 0.36% 0.22% 0.06% 0.07% EBITDA 3,000.66 2,861.17 1,823.21 1,873.02 1,262.75 1,447.14 1,418.32 1,166.25 1,015.38 815.97 691.28 EBITDA Margin 41.68% 41.05% 33.80% 37.87% 32.45% 35.61% 37.56% 37.44% 40.10% 38.04% 37.09% Other Income 92.45 62.56 189.63 155.63 113.44 74.89 97.44 44.70 70.60 44.81 56.05 Interest 0.92 2.10 7.14 4.68 2.37 3.36 4.74 2.88 2.96 2.59 4.61 Depreciation 272.65 255.59 186.24 168.90 142.49 123.33 118.18 136.00 92.12 76.95 62.08 PBT 2,819.54 2,666.04 1,819.46 1,855.07 1,231.33 1,395.34 1,392.84 1,072.08 990.92 781.24 680.63 Tax 770.20 681.75 442.92 502.33 354.32 334.92 267.06 220.56 217.58 179.23 147.36 Tax Rate 27.32% 25.57% 24.34% 27.08% 28.78% 24.00% 19.17% 20.57% 21.96% 22.94% 21.65% PAT 2,049.34 1,984.29 1,376.54 1,352.74 877.01 1,060.42 1,125.78 851.52 773.34 602.01 533.26 PAT before Minority Interest 2,049.34 1,984.29 1,376.54 1,352.74 877.01 1,060.42 1,125.78 851.52 773.34 602.01 533.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 28.46% 28.47% 25.52% 27.35% 22.54% 26.09% 29.81% 27.34% 30.54% 28.07% 28.61% PAT Growth 28.39% 44.15% 1.76% 54.24% -17.30% -5.81% 32.21% 10.11% 28.46% 12.89% EPS 77.19 74.74 51.85 50.95 33.03 39.94 42.40 32.07 29.13 22.67 20.09

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 9,271.57 7,316.69 6,973.31 5,959.65 5,408.91 4,357.04 3,561.96 3,034.42 2,553.28 2,174.80 Share Capital 53.09 53.09 53.09 53.09 53.09 53.09 26.55 26.55 26.55 26.55 Total Reserves 9,218.48 7,263.60 6,920.22 5,906.56 5,355.82 4,303.95 3,535.41 3,007.87 2,526.73 2,148.25 Non-Current Liabilities 363.48 294.48 993.72 1,769.95 1,418.95 92.33 847.80 656.71 477.08 77.75 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.47 1.05 1.55 2.10 2.56 Long Term Provisions 25.42 20.52 772.54 1,577.26 1,288.92 11.57 714.30 533.49 388.43 1.65 Current Liabilities 1,704.78 1,796.64 832.52 640.49 655.84 516.12 772.32 623.14 551.59 550.42 Trade Payables 748.78 580.34 483.31 405.65 442.30 230.42 224.38 148.69 158.31 157.31 Other Current Liabilities 337.25 286.51 242.50 170.79 176.52 239.46 202.73 146.55 129.35 134.70 Short Term Borrowings 0.35 33.63 105.60 63.11 35.74 41.42 25.07 16.32 30.51 50.20 Short Term Provisions 618.40 896.16 1.11 0.94 1.28 4.81 320.14 311.58 233.42 208.21 Total Liabilities 11,339.83 9,407.81 8,799.55 8,370.09 7,483.70 4,965.49 5,182.08 4,314.27 3,581.95 2,802.97 Net Block 3,699.01 2,776.26 2,087.44 1,995.88 1,558.95 1,438.64 1,308.73 1,221.60 908.50 738.19 Gross Block 4,685.46 3,508.06 2,633.29 2,372.92 1,793.57 2,195.42 1,952.40 1,739.79 1,337.88 1,091.63 Accumulated Depreciation 986.45 731.80 545.85 377.04 234.62 756.78 643.67 518.19 429.38 353.44 Non Current Assets 4,598.63 3,852.94 4,152.06 3,816.18 3,444.55 1,907.39 2,386.10 2,034.87 1,708.04 1,051.62 Capital Work in Progress 710.62 919.69 491.91 119.76 443.57 263.91 218.18 144.48 303.41 181.58 Non Current Investment 7.37 7.37 554.62 7.37 8.37 10.19 2.82 2.82 2.82 2.82 Long Term Loans & Adv. 172.42 144.18 1,012.93 1,688.04 1,424.88 188.87 856.03 665.87 493.23 126.99 Other Non Current Assets 9.21 5.44 5.16 5.13 8.78 5.78 0.35 0.09 0.07 1.63 Current Assets 6,741.20 5,554.87 4,647.49 4,553.91 4,039.15 3,058.10 2,795.98 2,279.41 1,873.91 1,751.35 Current Investments 0.00 971.35 1,398.34 1,889.29 1,630.72 802.85 733.00 501.88 407.81 477.04 Inventories 2,042.70 1,744.17 1,663.18 1,281.39 1,255.76 1,162.89 1,114.90 893.27 805.95 650.97 Sundry Debtors 1,745.56 1,533.21 1,282.24 1,112.11 1,002.89 966.12 823.03 791.64 558.90 533.97 Cash & Bank 2,142.01 107.36 105.20 91.48 66.47 59.38 56.66 35.77 34.68 21.82 Other Current Assets 810.93 199.04 11.56 19.49 83.31 66.86 68.39 56.86 66.56 67.55 Short Term Loans & Adv. 688.54 999.74 186.97 160.15 63.14 48.19 54.14 47.56 57.28 62.14 Net Current Assets 5,036.42 3,758.23 3,814.97 3,913.42 3,383.31 2,541.98 2,023.66 1,656.26 1,322.32 1,200.92 Total Assets 11,339.83 9,407.81 8,799.55 8,370.09 7,483.70 4,965.49 5,182.08 4,314.28 3,581.95 2,802.97

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 9,294.61 7,309.92 6,957.15 5,924.80 5,357.39 4,293.31 3,495.36 2,963.35 2,500.60 2,131.52 Share Capital 53.09 53.09 53.09 53.09 53.09 53.09 26.55 26.55 26.55 26.55 Total Reserves 9,241.52 7,256.83 6,904.06 5,871.71 5,304.30 4,240.21 3,468.81 2,936.80 2,474.05 2,104.98 Non-Current Liabilities 363.94 294.57 991.38 1,768.91 1,411.75 85.17 841.57 650.05 469.75 71.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.47 1.05 1.55 2.10 2.56 Long Term Provisions 25.42 20.52 772.54 1,577.26 1,288.92 11.57 714.30 533.49 388.43 1.65 Current Liabilities 1,728.35 1,820.53 846.75 653.42 659.45 519.50 775.53 627.41 554.45 553.78 Trade Payables 763.20 590.72 492.26 411.21 445.80 232.69 226.87 151.70 160.44 159.54 Other Current Liabilities 340.42 290.09 243.59 175.46 176.63 240.58 203.45 147.80 130.08 135.83 Short Term Borrowings 0.35 33.63 105.60 63.11 35.74 41.42 25.07 16.32 30.51 50.20 Short Term Provisions 624.38 906.09 5.30 3.64 1.28 4.81 320.14 311.58 233.42 208.21 Total Liabilities 11,386.90 9,425.02 8,795.28 8,347.13 7,428.59 4,897.98 5,112.46 4,240.81 3,524.80 2,756.65 Net Block 3,703.87 2,781.85 2,087.77 1,996.19 1,559.19 1,438.77 1,308.89 1,221.84 908.72 738.42 Gross Block 4,691.86 3,514.25 2,633.93 2,373.45 1,793.95 2,196.08 1,953.02 1,740.34 1,338.35 1,092.05 Accumulated Depreciation 987.99 732.40 546.16 377.26 234.76 757.32 644.13 518.50 429.63 353.64 Non Current Assets 4,596.30 3,851.49 4,145.23 3,812.01 3,418.08 1,870.93 2,340.06 1,984.45 1,660.69 1,005.71 Capital Work in Progress 710.62 919.69 491.91 119.76 443.57 263.91 218.18 144.48 303.41 181.58 Non Current Investment 0.01 0.01 547.26 0.01 0.01 0.01 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 172.59 144.50 1,012.93 1,688.23 1,406.48 162.44 812.63 618.03 448.49 83.68 Other Non Current Assets 9.21 5.44 5.36 7.82 8.83 5.80 0.35 0.09 0.07 1.63 Current Assets 6,790.60 5,573.53 4,650.05 4,535.12 4,010.51 3,027.04 2,772.40 2,256.35 1,864.11 1,750.95 Current Investments 0.00 971.35 1,398.34 1,889.28 1,630.72 802.85 733.00 501.88 407.81 477.04 Inventories 2,145.23 1,863.86 1,772.34 1,350.67 1,319.91 1,207.83 1,162.64 932.42 835.69 678.96 Sundry Debtors 1,676.52 1,413.35 1,163.37 1,014.36 900.92 880.92 741.64 723.70 512.00 495.08 Cash & Bank 2,156.03 122.63 115.26 112.46 78.70 73.43 65.22 40.51 40.89 30.94 Other Current Assets 812.82 202.57 142.20 124.98 80.26 62.01 69.89 57.85 67.71 68.93 Short Term Loans & Adv. 684.40 999.77 58.54 43.37 59.59 42.88 54.98 48.16 57.97 63.25 Net Current Assets 5,062.25 3,753.00 3,803.30 3,881.70 3,351.06 2,507.54 1,996.87 1,628.95 1,309.66 1,197.16 Total Assets 11,386.90 9,425.02 8,795.28 8,347.13 7,428.59 4,897.97 5,112.46 4,240.80 3,524.80 2,756.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 1,947.05 1,208.47 964.06 764.72 1,149.11 1,036.34 822.44 558.15 482.83 334.05 PBT 2,627.87 1,813.29 1,833.23 1,219.36 1,388.23 1,375.29 1,067.18 1,008.64 791.58 694.86 Adjustment 186.66 52.55 86.71 29.72 81.10 69.27 108.33 70.06 55.01 21.08 Changes in Working Capital -234.52 -211.40 -472.96 -215.81 -18.52 -147.34 -141.64 -307.22 -189.31 -259.15 Cash after chg. in Working capital 2,580.01 1,654.44 1,446.98 1,033.27 1,450.81 1,297.23 1,033.87 771.48 657.29 456.79 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -632.96 -445.97 -482.92 -268.55 -301.70 -260.89 -211.43 -213.34 -174.46 -122.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 75.34 -81.38 -684.24 -475.89 -1,137.41 -411.16 -520.77 -305.08 -254.49 -204.35 Net Fixed Assets -968.33 -1,302.55 -632.52 -255.54 222.19 -288.75 -286.31 -242.98 -368.08 -284.15 Net Investments 971.35 974.24 -56.30 -257.57 -826.05 -77.22 -231.12 -94.07 69.23 48.60 Others 72.32 246.93 4.58 37.22 -533.55 -45.19 -3.34 31.97 44.36 31.20 Cash from Financing Activity -33.97 -1,091.25 -245.94 -314.17 3.27 -630.34 -302.95 -248.50 -230.76 -131.11 Net Cash Inflow / Outflow 1,988.42 35.84 33.88 -25.34 14.97 -5.17 -1.28 4.57 -2.43 -1.40 Opening Cash & Equivalents 27.88 -7.96 -41.84 -16.50 -31.47 9.06 10.35 5.78 8.20 9.60 Closing Cash & Equivalent 2,016.30 27.88 -7.96 -41.84 -16.50 3.89 9.06 10.35 5.78 8.20

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 1,946.93 1,215.94 954.30 775.86 1,150.37 1,037.86 826.33 556.75 479.97 338.36 PBT 2,666.04 1,819.46 1,855.07 1,231.33 1,395.34 1,392.84 1,072.08 990.92 781.24 680.63 Adjustment 189.29 60.01 83.51 32.19 93.87 60.94 91.24 77.55 59.25 26.87 Changes in Working Capital -264.08 -218.30 -499.84 -219.11 -37.14 -155.03 -125.55 -298.39 -186.05 -242.47 Cash after chg. in Working capital 2,591.25 1,661.17 1,438.74 1,044.41 1,452.07 1,298.75 1,037.76 770.07 654.44 465.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -644.32 -445.23 -484.44 -268.55 -301.70 -260.89 -211.43 -213.32 -174.47 -126.68 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 75.13 -83.47 -685.40 -478.30 -1,139.60 -406.41 -520.84 -305.15 -254.54 -204.41 Net Fixed Assets -968.33 -1,302.55 -632.52 -255.54 222.19 -288.75 -286.31 -242.98 -368.08 -284.15 Net Investments 971.35 974.24 -56.30 -257.57 -826.05 -77.22 -231.12 -94.07 69.23 48.60 Others 72.11 244.84 3.42 34.81 -535.74 -40.44 -3.41 31.90 44.31 31.14 Cash from Financing Activity -34.89 -1,091.42 -245.94 -314.16 2.38 -631.12 -302.95 -248.50 -230.76 -131.11 Net Cash Inflow / Outflow 1,987.17 41.05 22.96 -16.60 13.15 0.33 2.54 3.10 -5.33 2.84 Opening Cash & Equivalents 43.15 2.10 -20.86 -4.26 -17.41 17.62 15.09 11.99 17.32 14.48 Closing Cash & Equivalent 2,030.32 43.15 2.10 -20.86 -4.26 17.95 17.62 15.09 11.99 17.32

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 349.28 275.63 262.70 224.51 203.76 164.13 134.18 114.30 96.18 81.92 ROA 18.84% 15.08% 15.52% 10.97% 16.92% 21.89% 17.84% 20.05% 19.15% 21.36% ROE 23.57% 19.21% 20.61% 15.30% 21.57% 28.06% 25.68% 28.34% 25.86% 27.29% ROCE 31.64% 25.23% 28.06% 21.31% 28.27% 34.53% 32.22% 35.88% 32.98% 34.28% Fixed Asset Turnover 1.66 1.73 1.95 1.84 2.04 1.81 1.69 1.65 1.77 1.88 Receivable days 88.01 96.75 89.55 100.59 88.38 87.08 94.72 97.33 93.02 90.80 Inventory Days 101.65 117.10 110.13 120.67 108.57 110.86 117.81 122.46 124.00 116.99 Payable days 60.06 55.01 52.95 60.35 47.52 35.14 33.59 36.19 42.55 42.75 Cash Conversion Cycle 129.61 158.84 146.72 160.91 149.43 162.79 178.93 183.60 174.46 165.04 Total Debt/Equity 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.03 Interest Cover 1452.86 258.94 398.66 528.86 417.89 349.89 375.24 345.75 310.56 152.46

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 350.15 275.38 262.09 223.20 201.82 161.73 131.67 111.63 94.20 80.29 ROA 19.07% 15.11% 15.78% 11.12% 17.21% 22.49% 18.21% 19.92% 19.17% 21.20% ROE 23.90% 19.30% 21.00% 15.55% 21.98% 28.91% 26.37% 28.31% 25.99% 27.15% ROCE 32.07% 25.36% 28.50% 21.68% 28.75% 35.57% 33.06% 36.04% 33.21% 34.20% Fixed Asset Turnover 1.70 1.75 1.98 1.88 2.06 1.83 1.70 1.66 1.78 1.90 Receivable days 80.91 87.17 80.35 89.33 79.19 77.83 85.12 88.42 85.08 83.45 Inventory Days 104.98 123.02 115.23 124.56 112.34 113.70 121.69 126.52 127.96 121.31 Payable days 59.72 54.82 52.21 60.15 47.14 35.06 33.55 36.16 42.47 42.66 Cash Conversion Cycle 126.17 155.38 143.37 153.75 144.39 156.47 173.26 178.78 170.58 162.09 Total Debt/Equity 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.03 Interest Cover 1270.54 255.83 397.38 520.55 416.28 294.75 373.59 336.24 302.96 148.53

Top Investors:

sbi mutual fund

qualified institutional buyer

axis mutual fund trustee limited

government pension fund global

life insurance corporation of india

Annual Reports:

News Update:

Divi’s Laboratories reports 13% rise in Q1 consolidated net profit
9th Aug 2021, 12:21 PM

Total consolidated income of the company increased by 14.24% at Rs 1996.61 crore for Q1FY22
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback